| Literature DB >> 36185194 |
Sai-Li Duan1,2, Lin Qi1,3, Ming-Hao Li1,3, Long-Fei Liu1,3, Yong Wang1,3, Xiao Guan1,3.
Abstract
Background: The purpose of this study was to define and analyze the characteristics of the top 100 most-cited articles and reviews on the topic of pheochromocytomas and paragangliomas (PPGLs) by using bibliometric methods.Entities:
Keywords: PPGL; bibliometric study; paragangliomas; pheochromocytomas; top 100
Year: 2022 PMID: 36185194 PMCID: PMC9523535 DOI: 10.3389/fonc.2022.993921
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1The initial search process in Web of Science (WOS).
Figure 2Citations analysis on publication year. (A) The relation between publication year and number of publications. (B) The relation between publication year and number of citations.
Journals that published over two papers in the top 100 most-cited papers.
| Journal | Number of published papers | Total number of citations | Average citation | IF 2019 | 5-year IF |
|---|---|---|---|---|---|
|
| 23 | 5,528 | 240.35 | 5.399 | 5.879 |
|
| 4 | 1,587 | 396.75 | 74.699 | 72.098 |
|
| 4 | 764 | 191.00 | 4.8 | 5.129 |
|
| 3 | 1,311 | 437.00 | 10.502 | 10.344 |
|
| 3 | 966 | 322.00 | 26.602 | 30.237 |
|
| 3 | 803 | 267.67 | 5.101 | 5.362 |
|
| 3 | 1,542 | 514.00 | 45.54 | 47.677 |
|
| 3 | 1,258 | 419.33 | 27.605 | 30.334 |
|
| 3 | 658 | 219.33 | 7.931 | 8.237 |
IF, impact factor.
Authors who contributed at least 2 papers to the top 100 most-cited papers list.
| First author | Number of top-cited papers | Total cited times | Average citations per paper | Corresponding author | Number of top-cited papers | Total cited times | Average citations per paper |
|---|---|---|---|---|---|---|---|
| Eisenhofer, G | 8 | 1,537 | 192.125 | Pacak, K | 8 | 1,512 | 189 |
| Burnichon, N | 4 | 1,008 | 252 | Eisenhofer, G | 7 | 1,397 | 199.571 |
| Timmers, HJLM | 4 | 806 | 201.5 | Gimenez-Roqueplo, AP | 7 | 1,670 | 238.571 |
| Amar, L | 3 | 884 | 294.667 | Baysal, BE | 3 | 1,557 | 519 |
| Baysal, BE | 3 | 1,557 | 519 | Dahia, PLM | 3 | 837 | 279 |
| Gimenez-Roqueplo, AP | 3 | 623 | 207.667 | Neumann, HPH | 3 | 1,755 | 585 |
| Pacak, K | 3 | 800 | 266.667 | Plouin, PF | 3 | 480 | 160 |
| Bayley, JP | 2 | 317 | 158.5 | Young, WF | 3 | 725 | 241.667 |
| Carney, JA | 2 | 468 | 234 | Burnichon, N | 2 | 615 | 307.5 |
| Dahia, PLM | 2 | 576 | 288 | Carney, JA | 2 | 468 | 234 |
| Favier, J | 2 | 367 | 183.5 | Cascon, A | 2 | 470 | 235 |
| Ilias, I | 2 | 355 | 177.5 | Eng, C | 2 | 483 | 241.5 |
| Lenders, JWM | 2 | 1,511 | 755.5 | Favier, J | 2 | 537 | 268.5 |
| Mannelli, M | 2 | 333 | 166.5 | Lenders, JWM | 2 | 1511 | 755.5 |
| Neumann, HPH | 2 | 1,524 | 762 | Mannelli, M | 2 | 333 | 166.5 |
| Plouin, PF | 2 | 269 | 134.5 | Taschner, PEM | 2 | 279 | 139.5 |
| Walther, MM | 2 | 343 | 171.5 | Timmers, HJLM | 2 | 471 | 235.5 |
| Tischler, AS | 2 | 550 | 275 | ||||
| Walther, MM | 2 | 343 | 171.5 |
Countries that published at least one paper in the top 100 most-cited papers.
| Countries | Number of publications | Total citations | Average citations per paper |
|---|---|---|---|
| USA | 51 | 12,914 | 253.2157 |
| France | 17 | 3,920 | 230.5882 |
| Netherlands | 8 | 1,954 | 244.25 |
| Germany | 7 | 2,990 | 427.1429 |
| Italy | 4 | 640 | 160 |
| Spain | 4 | 966 | 241.5 |
| Austria | 2 | 323 | 161.5 |
| Australia | 2 | 539 | 269.5 |
| England | 1 | 768 | 768 |
| Greece | 1 | 196 | 196 |
| South Korea | 1 | 176 | 176 |
| Sweden | 1 | 187 | 187 |
| Switzerland | 1 | 150 | 150 |
| Total | 100 | 25,723 | 257.23 |
Institutions that published at least two papers in the top 100 most-cited papers.
| Institutions | Number of papers | Total citation times | Citations per paper |
|---|---|---|---|
| National Institutes of Health (NIH)—USA NIH | 17 | 3,250 | 191.176 |
| APHP Hop Europeen Georges Pompidou | 11 | 2,627 | 238.818 |
| Mayo Clinic Mayo Clin and Mayo Fdn | 6 | 1,333 | 222.167 |
| Leiden University Leiden Univ, Med Ctr | 4 | 600 | 150.000 |
| University of Freiburg Univ Freiburg | 4 | 1,993 | 498.250 |
| University of Texas System University | 4 | 1,013 | 253.250 |
| Pennsylvania Commonwealth System of Higher Education (PCSHE) University of Pittsburgh Univ Pittsburgh, Med Ctr | 3 | 1,557 | 519.000 |
| Spanish National Cancer Research Centre | 3 | 827 | 275.667 |
| Harvard University | 3 | 691 | 230.333 |
| Institut National de la Sante et de la Recherche Medicale (Inserm) Universite de Paris INSERM | 3 | 715 | 238.333 |
| Erasmus University | 2 | 412 | 206.000 |
| James Cancer Hospital and Solove Research Institute Ohio State University Ohio State Univ | 2 | 483 | 241.500 |
| Radboud University Nijmegen Radboud Univ Nijmegen, Med Ctr | 2 | 942 | 471.000 |
| Royal North Shore Hospital Royal N Shore Hosp | 2 | 539 | 269.500 |
| Technische Universitat Dresden Univ Dresden | 2 | 331 | 165.500 |
| Tufts Medical Center Tufts Med Ctr | 2 | 550 | 275.000 |
| United States Department of Defense Armed Forces Inst Pathol | 2 | 495 | 247.500 |
| University of Florence Univ Florence | 2 | 333 | 166.500 |
WOS categories in the top 100 most-cited papers.
| WOS categories | Times |
|---|---|
| Endocrinology and metabolism | 34 |
| Oncology | 21 |
| Genetics and heredity | 16 |
| Medicine, general and internal | 11 |
| Radiology, nuclear medicine and medical imaging | 6 |
| Biochemistry and molecular biology | 4 |
| Cell biology | 3 |
| Multidisciplinary sciences | 3 |
| Pathology | 3 |
| Surgery | 3 |
| Urology and nephrology | 3 |
| Medical laboratory technology | 2 |
| Peripheral vascular disease | 1 |
| Anesthesiology | 1 |
| Biotechnology and applied microbiology | 1 |
| Cardiac and cardiovascular systems | 1 |
| Dentistry, oral surgery and medicine | 1 |
| Gastroenterology and hepatology | 1 |
| Medicine, research and experimental | 1 |
| Neurosciences | 1 |
| Otorhinolaryngology | 1 |
| Peripheral vascular disease | 1 |
| Respiratory system | 1 |
| Toxicology | 1 |
WOS, Web of Science.
Keywords that appeared at least five times in the top 100 most-cited papers.
| Keywords | Numbers | Keywords | Numbers |
|---|---|---|---|
| Gene-mutations | 41 | Familial pheochromocytoma | 7 |
| Diagnosis | 30 | MEN | 7 |
| Complex-II gene | 26 | Sporadic pheochromocytoma | 7 |
| MIBG | 23 | Susceptibility | 7 |
| VHL | 20 | Cancer | 6 |
| Malignant pheochromocytoma | 14 | Carotid-body tumors | 6 |
| Succinate-dehydrogenase | 14 | Expression | 6 |
| MEN-2 | 11 | Head | 6 |
| PET | 11 | Hereditary paragangliomas | 6 |
| Tumors | 11 | Nonchromaffin paragangliomas | 6 |
| Management | 10 | SDHB | 6 |
| Localization | 9 | ||
| Tumor-suppressor gene | 9 | ||
| Benign | 8 | ||
| Gene | 8 | ||
| RET | 8 | ||
| Catecholamines | 7 |
Figure 3The relationship between top 5 keywords and year.